Human cDNA-Expressed Cytochrome P450 IA2: Mutagen Activation and Substrate Specificity†
Toshifumi Aoyama
Laboratory of Molecular Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Search for more papers by this authorFrank J. Gonzalez
Laboratory of Molecular Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Search for more papers by this authorCorresponding Author
Harry V. Gelboin
Laboratory of Molecular Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
NIH, National Cancer Institute, Laboratory of Molecular Carcinogenesis, Bldg. 37, Rm 3E24, Bethesda, MD 20892Search for more papers by this authorToshifumi Aoyama
Laboratory of Molecular Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Search for more papers by this authorFrank J. Gonzalez
Laboratory of Molecular Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Search for more papers by this authorCorresponding Author
Harry V. Gelboin
Laboratory of Molecular Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
NIH, National Cancer Institute, Laboratory of Molecular Carcinogenesis, Bldg. 37, Rm 3E24, Bethesda, MD 20892Search for more papers by this authorThe nomenclature used in this report is that described by Nebert et al., (39). The P450 IA2 is coded by the CYP1A2 gene.
Abstract
The vaccinia virus cDNA expression system was used to produce human cytochrome P450 IA2 in a hepatoma cell line that is devoid of significant basal levels of P450. The expressed enzyme yielded a reduced carbon monoxide-bound difference spectrum with a λmax of 449 nm. Catalytic activities and mutagen activation ability of the human enzyme were assessed and directly compared with results obtained with the orthologous mouse IA2, which was also expressed using vaccinia virus. Both the human and mouse enzymes were able to catalyze efficiently the p-hydroxylation of aniline. Mouse IA2 also catalyzed ethoxyresorufin O-deethylation, and its activity was sevenfold greater than expressed human IA2. The mouse and human enzymes also activated several promutagens and procarcinogens. Mouse IA2 was five- to sevenfold more active than the human enzyme for activation of the procarcinogens 2-acetylaminofluorene and benzo[a]pyrene-trans-7,8-dihydrodiol and the promutagens Glu-P-2 and Trp-P-1. Comparable activities were observed with 2-aminoanthracene, 2-aminofluorene, and Glu-P-1. These data demonstrate the utility of cDNA expression for examining the activities of human P450s and further suggest potentially important differences in catalytic activities of orthologous P450s found in different species.
References
- 1 Gelboin HV. Benzo[ a]pyrene metabolism, activation and carcinogenesis: Role and regulation of mixed function oxidases and related enzymes. Physiol Rev 60: 1107–1166, 1980.
- 2 Guengerich FP. Enzymology of rat liver cytochromes P450. In: FP Guengerich (ed), Mammalian Cytochromes P450, vol. 1. CRC Press, Boca Raton, FL 1987, p 1–54.
- 3 Distlerath LM, Guengerich FP. Enzymology of human liver cytochromes P450. In: FR Guengerich (ed), Mammalian Cytochromes P450, vol. 1. CRC Press, Boca Raton, FL 1987, p 133–198.
- 4
Ortiz-Montellano PR.
Cytochrome P-450,
Plenum Press, NY.
1986,
p 1–539.
10.1007/978-1-4757-9939-2_1 Google Scholar
- 5 Gelboin HV, Miller JA, Miller EC. The in vitro formation of proteinbound derivatives of amino azo dyes by rat liver preparations. Cancer Res 19: 975–985, 1959.
- 6 Gelboin HV. A microsomal dependent binding of benzo[a]pyrene to DNA. Cancer Res 19: 1272–1276, 1969.
- 7 Grover PL, Sims P. Enzyme catalyzed reactions of polycyclic hydrocarbons with deoxyribonucleic acid and protein in vitro. Biochem J 110: 159, 1968.
- 8 Ames BN, McCann J, Yamasaki E. Methods for detecting carcinogens and mutagens with the salmonella-Mammalian mutagenicity test. Mutat Res 31: 347–364, 1975.
- 9 Raineri R, Poiley JA, Pienta RJ, Andrews AW. Metabolic activation of carcinogens in the Salmonella mutagenicity assay by hamster and rat liver S-9 preparations. Environ Mutagenesis 3: 71–84, 1981.
- 10 Oeda K, Sakaki T, Ohkawa H. Expression of rat liver cytochrome P-450 MC cDNA in Saccharomyces cerevisiae. DNA 4: 203–210, 1985.
- 11 Hardwick JP, Song BJ, Huberman E, Gonzalez FJ. Isolation of complementary DNA sequence, and regulation of rat hepatic lauric acid w-Hydroxylase: Identification of a new cytochrome P-450 gene family. J Biol Chem 262: 801–810, 1987.
- 12 Nagata K, Matsunaga T, Gillette J, Gelboin HV, Gonzalez FJ. Rat testosterone 7≈-Hydroxylase: isolation, sequence and expression of cDNA and its developmental regulation and induction by 3-Methylcholanthrene. J Biol Chem 262: 2787–2793, 1987.
- 13 Gonzalez FJ, Schmid BJ, Umeno M, et al. Human P450 PCN 1: Sequence, chromosome localization and direct evidence through cDNA expression that P450 PCN1 is nifedipine oxidase. DNA 7: 79–86, 1988.
- 14 Gonzalez FJ, Skoda RC, Kimura S, et al. Characterization of the common genetic defect in humans deficient in debrisoquine metabolism. Nature 331: 442–446, 1988.
- 15 Zuber MX, Simpson ER, Waterman MR. Expression of bovine 17≈-Hydroxylase cytochrome P-450 cDNA in non steroidogenic (cOS1) cells. Science 234: 1258–1261, 1987.
- 16 Aoyama T, Yamano S, Waxman DJ, et al. Cytochrome P450 hPCN3 a novel P450 IIIA gene product that is differentially expressed in adult human liver: cDNA and deduced amino acid sequence and distinct specificities of cDNA-Expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporine. J Biol Chem 264: 10388–10395, 1989.
- 17 Aoyama T, Korzekwa K, Nagata K, et al. CDNA-Directed expression of rat testosterone 7≈-Hydroxylase using the modified vaccinia virus, T7-RNA-Polymerase system and evidence for 6α-Hydroxylation and λ6-Testosterone formation. Eur J Biochem 181: 331–336, 1989.
- 18 Aoyama T, Gonzalez FJ, Gelboin HV. Mutagen activation by cDNA-Expressed P1450, P3450, and P450a. Mol Carcinog 1: 253–259, 1989.
- 19 Battula N, Sagara J, Gelboin HV. Expression of P1450 and P3450 DNA coding sequences as enzymatically active cytochromes P-450 in mammalian cells. Proc Natl Acad Sci USA 84: 4073–4077, 1987.
- 20 Chakrabarti S, Brechling K, Moss B. Vaccinia virus expression vector: Coexpression of β galactosidase provides visual screening of recombinant virus plaques. Mol Cell Biol 5: 3403–3409, 1985.
- 21 Kimura S, Gonzalez FJ, Nebert DW, The murine Ah locus: Comparison of the complete cytochrome P1450 and P3450 cDNA nucle-Otide and amino acid sequences. J Biol Chem 259: 10705–10713, 1984.
- 22 Jaiswal AK, Nebert DW, Gonzalez FJ. Human P3 450: cDNA and complete amino acid sequence. Nucl Acid Res 14: 6773–6774, 1986.
- 23 Yamano S, Aoyama T, McBride OW, et al. Human NADPH-P450 oxidoreductase: Complementary DNA cloning, sequence and vaccinia virus-Mediated expression, and localization of the CYPOR gene to chromosome 7. Mol Pharm 35: 83–88, 1989.
- 24 Koop DR, Morgan ET, Tarr GE, Coon MJ. Purification and characterization of a unique isozyme of cytochrome P450 from liver microsomes of ethanol-Treated rabbits. J Biol Chem 255: 304–309, 1982.
- 25 Guengerich FP, Dannan GA, Wright ST, Martin MV, Kaminsky LS. Purification and characterization of liver microsomal cytochromes P450: Electrophoretic, spectral, catalytic, and immunochemical properties and inducibility of eight isozymes isolated from rats treated with phenobarbital or β-Naphthoflavone. Biochemistry 21: 6019–6030, 1982.
- 26 Greenlee WF, Poland A. An improved assay of 7-Ethoxycoumarin O-Deethylase activity: Induction of the hepatic enzyme in C57BL/6J and DBA/2J mice by phenobarbital, 3-Methylcholanthrene, and 2,3,7,8-Tetrachloro-Dibenzo-P-Dioxin. J Pharmacol Exp Ther 205: 596–608, 1978.
- 27 Wood AW, Swinney DC, Thomas DE, et al. Mechanism of andro-Stenedione formation from testosterone and epitestosterone catalyzed by purified cytochrome P450b. J Biol Chem 263: 17322–17332, 1988.
- 28 Omura T, Sato R. The carbon monoxide-Binding pigment of liver microsomes. II. Solubilization.purification and properties. J Biol Chem 239: 2379–2385, 1964.
- 29 Johnson EF, Levitt DS, Muller-Eberhard U, et al. Catalysis of divergent pathways of 2-Acetylaminofluorene metabolism by multiple forms of cytochrome P450. Cancer Res 40: 4456–4462, 1980.
- 30 McManus ME, Minchin RF, Sanderson N, et al. Metabolic processing of 2-Acetylaminofluorene by microsomes and six highly-Purified cytochrome P450 forms from rabbit liver. Carcinogenesis 5: 1717–1722, 1984.
- 31 Goldstein JA, Weaver R, Sunheimer DW. Metabolism of 2-Acetylaminofluorene by two 3-Methylcholanthrene-Inducible forms of rat liver cytochromes P-450. Cancer Res 44: 3768–3776, 1984.
- 32 Kamataki T, Maeda K, Yamazoe Y, et al. A high-Spin form of cytochrome P450 highly purified from polychlorinated biphenyl-Treated rats. Mol Pharmacol 24: 146–155, 1983.
- 33 Hammons GJ, Guengerich FP, Weis CC, et al. Metabolic oxidation of carcinogenic arylamines by rat, dog and human hepatic microsomes and by purified flavin-Containing and cytochrome P450 monooxygenases. Cancer Res 45: 3578–3586, 1985.
- 34 Masson HA, Ioannides C, Gorrod JW, et al. The role of highly purified cytochrome P-450 isozymes in the activation of 4-Amino-Biphenyl to mutagenic products in the Ames test. Carcinogenesis 4: 1583–1594, 1983.
- 35 Yamazoe Y, Shimada M, Kamataki T, et al. Microsomal activation of 2-Amino-3-Methylimidazo(4,5-F)quinoline, a pyrolysate of sardine and beef extracts, to a mutagenic intermediate. Cancer Res 43: 5768–5774, 1983.
- 36 McManus ME, Burges W, Synderwine E, et al. Specificity of rabbit cytochrome P450 isozymes involved in the metabolic activation of the food derived mutagen 2-Amino-3-Methylimidazo [4,5-F]quinoline. Cancer Res 48: 4513–4519, 1988.
- 37 Skoda RC, Gonzalez FJ, Demierre A, Meyer UA. Two mutant alleles of the human cytochrome P-450db1 gene (p450C2D1) associated with genetically deficient metabolism of debrisoquine and other drugs. Proc Natl Acad Sci USA 85: 5240–5243, 1988.
- 38 Shimada R, Iwasaki M, Martin MV, Guengerich FP. Human liver microsome P-450 enzymes involved in the bioactivation of pro-Carcinogens detected by umu gene response in Salmonella Typhi-Munium TA 1535/PSK 1002. Cancer Res 49: 3218–3228, 1989.
- 39 Nebert DW, Nelson DR, Adesnik M, et al. The P450 superfamily: Update on listing of all genes and recommended nomenclature for the chromosomal loci. DNA 8: 1–13, 1989.